Atypical aetiology in patients hospitalised with community-acquired pneumonia is associated with age, gender and season; a data-analysis on four Dutch cohorts

BMC Infectious Diseases

Volumn 16, Issue 1, 2016, Pages

  Raeven, Vivian M ^a,e   Spoorenberg, Simone M C ^a   Boersma, Wim G ^b   van de Garde, Ewoudt M W ^a,c   Cannegieter, Suzanne C ^d   Voorn, G P Paul ^a   Bos, Willem Jan W ^a   van Steenbergen, Jim E ^d,e  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b Medical Centre Alkmaar   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Aetiology; Atypical pathogens; Community acquired pneumonia; Demography; Pneumonia

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHLAMYDIA; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMUNITY ACQUIRED PNEUMONIA; COXIELLA BURNETII; DUTCHMAN; FEMALE; HOSPITAL PATIENT; HUMAN; LEGIONELLA; MAJOR CLINICAL STUDY; MALE; MYCOPLASMA PNEUMONIAE; SEASONAL VARIATION; SEX DIFFERENCE; AGE; CHLAMYDIA INFECTIONS; COMMUNITY-ACQUIRED INFECTIONS; FEVER; HOSPITALIZATION; ISOLATION AND PURIFICATION; LEGIONELLOSIS; MICROBIOLOGY; MIDDLE AGED; NETHERLANDS; ODDS RATIO; PNEUMONIA, BACTERIAL; PNEUMONIA, MYCOPLASMA; PROSPECTIVE STUDY; SEASON; VERY ELDERLY;

ANTIINFECTIVE AGENT;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHLAMYDIA; CHLAMYDIA INFECTIONS; COMMUNITY-ACQUIRED INFECTIONS; COXIELLA BURNETII; FEMALE; FEVER; HOSPITALIZATION; HUMANS; LEGIONELLA; LEGIONELLOSIS; MALE; MIDDLE AGED; MYCOPLASMA PNEUMONIAE; NETHERLANDS; ODDS RATIO; PNEUMONIA, BACTERIAL; PNEUMONIA, MYCOPLASMA; PROSPECTIVE STUDIES; SEASONS; SEX FACTORS;

EID: 84975299373     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-016-1641-9     Document Type: Article

References (33)

1. Lim WS, Baudouin SV, George RC, Hill AT, Jamieson C, Le Jeune I, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax. 2009;64 Suppl 3:1-55. iii.
2. Wiersinga W, Bonten M, Boersma W, Jonkers R, Aleva R, Kullberg B, et al. SWAB/NVALT (Dutch Working Party on Antibiotic Policy and Dutch Association of Chest Physicians) guidelines on the management of community-acquired pneumonia in adults. Neth J Med. 2012;70:90-101.
3. National Clinical Guideline Centre (UK). Pneumonia: Diagnosis and Management of Community- and Hospital-Acquired Pneumonia in Adults. 2014. https://www.nice.org.uk/guidance/cg191. Accessed 12 May 2015.
4. Dowell SF, Whitney CG, Wright C, Rose Jr CE, Schuchat A. Seasonal patterns of invasive pneumococcal disease. Emerg Infect Dis. 2003;9:574.
5. Schwarzmann SW, Adler JL, Sullivan RJ, Marine WM. Bacterial pneumonia during the Hong Kong influenza epidemic of 1968-1969: experience in a city-county hospital. Arch Intern Med. 1971;127:1037-41.
6. Den Boer J, Nijhof J, Friesema I. Risk factors for sporadic community-acquired Legionnaires' disease. A 3-year national case-control study. Public Health. 2006;120:566-71.
7. Brandsema P, Euser S, Karagiannis I, Den Boer J, van der Hoek W. Summer increase of Legionnaires' disease 2010 in The Netherlands associated with weather conditions and implications for source finding. Epidemiol Infect. 2014:142;2360-71.
8. Roest HJ, van Steenbergen J, Wijkmans C, van Duijnhoven Y, Stenvers O, Oomen T, et al. Q-koorts in 2008 in Nederland en de verwachting voor 2009. Tijdschr Diergeneeskd. 2009;134:300.
9. Brandsema P, Dijkstra F, Euser S, van Gageldonk-Lafeber A, de Lange M, Meijer A, et al. Jaarrapportage surveillance respiratoire infectieziekten 2012. National Institute for Public Health and the Environment. 2013. http://www.rivm.nl/dsresource?objectid=rivmp:228955&type=org&disposition=inline&ns_nc=1. Accessed 10 May 2015.
10. Marrie TJ, Poulin-Costello M, Beecroft MD, Herman-Gnjidic Z. Etiology of community-acquired pneumonia treated in an ambulatory setting. Respir Med. 2005;99:60-5.
11. Marston BJ, Lipman HB, Breiman RF. Surveillance for Legionnaires' disease: risk factors for morbidity and mortality. Arch Intern Med. 1994;154:2417-22.
12. Yung AP, Grayson ML. Psittacosis--a review of 135 cases. Med J Aust. 1988;148:228-33.
13. Raoult D, Tissot-Dupont H, Foucault C, Gouvernet J, Fournier PE, Bernit E, et al. Q fever 1985-1998: clinical and epidemiologic features of 1,383 infections. Medicine. 2000;79:109-23.
14. Almirall J, Blanquer J, Bello S. Community-acquired pneumonia among smokers. Arch Bronconeumol. 2014;50:250-4.
15. Liapikou A, Polverino E, Ewig S, Cillóniz C, Marcos MA, Mensa J, et al. Severity and outcomes of hospitalised community-acquired pneumonia in COPD patients. Eur Respir J. 2012;39:855-61.
16. Van der Eerden M, Vlaspolder F, De Graaff C, Groot T, Jansen H, Boersma W. Value of intensive diagnostic microbiological investigation in low-and high-risk patients with community-acquired pneumonia. European J Clin Microbiol Infect Dis. 2005;24:241-9.
17. Torres A, Ausina V. Empirical treatment of nonsevere community-acquired pneumonia: still a difficult issue. Eur Respir J. 1995;8:1996-8.
18. File Jr TM. Community-acquired pneumonia. Lancet. 2003;362:1991-2001.
19. Huijts SM, Boersma W, Grobbee D, Gruber W, Jansen K, Kluytmans J, et al. Predicting pneumococcal community acquired pneumonia in the emergency department. Clin Microbiol Infec. 2014;20:1316-22.
20. Boersma WG, Daniels J, Löwenberg A, Boeve W, van de Jagt EJ. Reliability of radiographic findings and the relation to etiologic agents in community-acquired pneumonia. Respir Med. 2006;100:926-32.
21. Meijvis SC, Hardeman H, Remmelts HH, Heijligenberg R, Rijkers GT, van Velzen-Blad H, et al. Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial. Lancet. 2011;377:2023-30.
22. Snijders D, Daniels JM, de Graaff CS, van der Werf TS, Boersma WG. Efficacy of corticosteroids in community-acquired pneumonia: a randomized double-blinded clinical trial. Am J Respir Crit Care Med. 2010;181:975-82.
23. Endeman H, Schelfhout V, Paul Voorn G, van Velzen-Blad H, Grutters JC, Biesma DH. Clinical features predicting failure of pathogen identification in patients with community acquired pneumonia. Scand J Infect Dis. 2008;40:715-20.
24. van der Eerden MM, Vlaspolder F, de Graaff CS, Groot T, Bronsveld W, Jansen HM, et al. Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomised study. Thorax. 2005;60:672-8.
25. Eliakim-Raz N, Robenshtok E, Shefet D, Gafter-Gvili A, Vidal L, Paul M, et al. Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults. Cochrane Database Syst Rev. 2012;9.
26. Mills GD, Oehley MR, Arrol B. Effectiveness of beta lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community acquired pneumonia: meta-analysis. BMJ. 2005;330:456.
27. Postma DF, van Werkhoven CH, van Elden LJ, Thijsen SF, Hoepelman AI, Kluytmans JA, et al. Antibiotic treatment strategies for community-acquired pneumonia in adults. N Engl J Med. 2015;372:1312-23.
28. Johansson N, Kalin M, Tiveljung-Lindell A, Giske CG, Hedlund J. Etiology of community-acquired pneumonia: increased microbiological yield with new diagnostic methods. Clin Infect Dis. 2010;50:202-9.
29. Templeton KE, Scheltinga SA, van den Eeden WC, Graffelman AW, van den Broek PJ, Claas EC. Improved diagnosis of the etiology of community-acquired pneumonia with real-time polymerase chain reaction. Clin Infect Dis. 2005;41:345-51.
30. Schneeberger P, Dorigo-Zetsma JW, Zee AVD, Bon MV, Opstal JV. Diagnosis of atypical pathogens in patients hospitalized with community-acquired respiratory infection. Scand J Infect Dis. 2004;36:269-73.
31. Boersma WG, Löwenberg A, Holloway Y, Kuttschrutter H, Snijder JA, Koeter GH. Pneumococcal capsular antigen detection and pneumococcal serology in patients with community acquired pneumonia. Thorax. 1991;46:902-6.
32. Cunha B. The atypical pneumonias: clinical diagnosis and importance. Clin Microbiol Infec. 2006;12:12-24.
33. Graffelman AW, Knuistingh Neven A, le Cessie S, Kroes AC, Springer MP, van den Broek PJ. Pathogens involved in lower respiratory tract infections in general practice. Br J Gen Pract. 2004;54:15-9.